Those Who Invested in Universal Health Services (NYSE:UHS) Three Years Ago Are up 65%
Those Who Invested in Universal Health Services (NYSE:UHS) Three Years Ago Are up 65%
It hasn't been the best quarter for Universal Health Services, Inc. (NYSE:UHS) shareholders, since the share price has fallen 13% in that time. But over three years, the returns would have left most investors smiling In the last three years the share price is up, 63%: better than the market.
對於Universal Health Services, Inc.(紐交所:UHS)的股東來說,這不是最好的一季度,因爲股價在這段時間內下跌了13%。但在過去三年中,收益讓大多數投資者露出了笑容。在過去三年中,股價上漲了63%,優於市場。
Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns.
讓我們看看更長期的基本面,看看它們是否與股東回報一致。
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
儘管高效市場假說仍然被一些人教授,但已經證明市場是過度反應的動態系統,投資者並不總是理性。評估公司周圍的情緒如何變化的一種缺陷但合理的方法是比較每股收益(EPS)與股價。
During three years of share price growth, Universal Health Services achieved compound earnings per share growth of 7.3% per year. This EPS growth is lower than the 18% average annual increase in the share price. This suggests that, as the business progressed over the last few years, it gained the confidence of market participants. That's not necessarily surprising considering the three-year track record of earnings growth.
在股價增長的三年中,Universal Health Services實現了每股收益年複合增長7.3%。這個每股收益增長低於18%的股價年平均漲幅。這表明,在過去幾年中,隨着業務的發展,它獲得了市場參與者的信心。考慮到這三年盈利增長的記錄,這並不讓人感到意外。
The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).
下圖顯示了每股收益隨着時間的變化(如果你點擊圖片,可以看到更詳細的信息)。
We know that Universal Health Services has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Universal Health Services will grow revenue in the future.
我們知道Universal Health Services最近改善了其淨利潤,但它會否增長營業收入?請查看分析師是否認爲Universal Health Services在未來會增加營業收入。
What About Dividends?
關於分紅派息的問題
It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. In the case of Universal Health Services, it has a TSR of 65% for the last 3 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!
考慮總股東回報以及任何給定股票的股價回報是非常重要的。股價回報僅反映股價的變化,而總股東回報(TSR)則包括分紅(假設它們被再投資)的價值以及任何折扣資本融資或剝離的好處。因此,對那些支付豐厚分紅的公司來說,TSR通常遠高於股價回報。就Universal Health Services而言,它在過去3年中TSR爲65%。這超過了我們之前提到的股價回報。這在很大程度上是由於其分紅支付!
A Different Perspective
不同的視角
We're pleased to report that Universal Health Services shareholders have received a total shareholder return of 47% over one year. And that does include the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 8% per year), it would seem that the stock's performance has improved in recent times. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - Universal Health Services has 1 warning sign we think you should be aware of.
我們高興地報告,Universal Health Services的股東在一年內獲得了47%的總股東回報。這包括了分紅。由於一年的TSR優於五年的TSR(後者爲每年8%),看起來該股票的表現最近有所改善。鑑於股價勢頭仍然強勁,值得更仔細地關注這隻股票,以免錯過機會。我發現長期看股價作爲業務表現的代理指標非常有趣。但要真正獲得洞察,我們還需要考慮其他信息。例如,風險 - Universal Health Services有1個警告信號,我們認爲您應該注意。
If you are like me, then you will not want to miss this free list of undervalued small caps that insiders are buying.
如果你像我一樣,那麼你一定不想錯過這份內部人士正在購買的被低估的小型股免費名單。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
請注意,本文中引用的市場回報反映了當前在美國交易所上市股票的市場加權平均回報。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。